1 / 34

Fistula in ano Therapeutic Options in High Anal Fistulas

Fistula in ano Therapeutic Options in High Anal Fistulas. A. Herold End- und Dickdarmzentrum Mannheim. subanodermal intersphincteric Fistulectomie distal transsphincteric. prox. transsphincteric suprasphincteric Flap procedure extrasphincteric. „Standard Treatment“ of high fistulas.

daniel_millan
Télécharger la présentation

Fistula in ano Therapeutic Options in High Anal Fistulas

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Fistula in anoTherapeuticOptions in High Anal Fistulas A. Herold End- und Dickdarmzentrum Mannheim

  2. subanodermal intersphincteric Fistulectomie distal transsphincteric prox. transsphincteric suprasphincteric Flap procedure extrasphincteric „Standard Treatment“ of high fistulas

  3. Flap procedure

  4. Mucosal - flap: Results (1) Type n Persistence Recurrence Transsph. 189 9 % 17 % Suprasph. 35 20 % 37 % Rectovag. 10 33 % 40 % Recurrent f. 21 38 % 47 % Crohn`s f. 29 28 % 48 % Athanasiadis S (1995): Int J Colorect Dis S. 153

  5. Mucosal - flap: Results (1) Type n Persistence Recurrence Healing Transsph. 189 9 % 17 % 74 % Suprasph. 35 20 % 37 % 43 % Rectovag. 10 33 % 40 % 37 % Recurrent f. 21 38 % 47 % 15 % Crohn`s f. 29 28 % 48 % 24 % Athanasiadis S (1995): Int J Colorect Dis S. 153

  6. Mucosal - flap: Results (2) Author Year n Type Rec „Incont“ Williams 91 13 mixed 0 % 62 % Garcia-Aguilar 85 151 mixed 2 % 10 % Wedell 87 30 trans 3 % 0 % Girona 87 96 trans/supra 3/8 % 8/19 % Oh 93 15 mixed 13 % - EDZ 03 41 trans 10 % 0 % Athanasiadis 94 189 trans 20 % 21 % Athanasiadis 83 81 mixed 21 % - Schouten 99 44 trans 25 % - Jones 87 39 trans 31 % - Gustafsson 02 42 trans 45 % 11 % Baeten 05 41 mixed 63 % (3Ja.) 17 %

  7. EDZ - Results(transsphincteric) n = 88, 04/2001 – 04/2004, Follow up: 35 mo (18 - 60 mo), 18% recurrent, 12% horse shoe, without Crohn´s, Transsphincteric: n = 41 Total Healing: n = 35 (85 %) Primary Healing: n = 27 (66 %)

  8. Re-Flap healed: n = 2 Fistulectomy: n = 5 Excision + Reconst: n = 1 Still persisting: n = 6 Total Healing Rate with Flap: 71 % (Incontinent: 0%) EDZ - Results(transsphincteric) n = 88, 04/2001 – 04/2004, Follow up: 35 mo (18 - 60 mo), 18% recurrent, 12% horse shoe, without Crohn´s, Transsphincteric: n = 41 Total Healing: n = 35 (85 %) Primary Healing: n = 27 (66 %) Persistence: n = 10 (24 %) Recurrence: n = 4 (10 %)

  9. Treatment Alternatives

  10. Anal - Fistula - Plug (AFP) Surgisis Anal Fistula Plug

  11. AFP - Procedure

  12. n Healing Fibrine 10 40 % Plug 15 87 % AFP: First Prospective Trial n = 25 Pat. (transsphincteric Fistulas), kryptoglandular, FU: 13 wks. Johnson E, Armstrong D (USA): Dis Colon Rectum 2006 S. 371

  13. n Healing Simple Fistula 13 100 % Komplex Fistula 7 45 % Total 20 80 % AFP: Prospective Trial n = 20 Pat. (36 transsphinctericFistulae), Crohn`s Disease, FU: 10 Mo. (3 – 24) O`Connor L, Armstrong D (USA): Dis Colon Rectum 2006 S. 1569

  14. Anal Fistula Plug: Results (USA) Author Year n FU Healing Robb (ASCRS 2004) 04 17 12 Mo Champagne (Armstrong)06 46 12 Mo Poirier (Abcarian)06 28 3 Mo Ky (New York) 07 42 3 Mo Christoforidis (Mineapolis) 07 57 3 Mo Cintron (USA) 07 28 3 Mo Abbas(Efron LA)07 17 7 Mo Safar (Wexner) 07 39 4 Mo

  15. Anal Fistula Plug: Results (USA) Author Year n FU Healing Robb (ASCRS 2004) 04 17 12 Mo 65 % Champagne (Armstrong)06 46 12 Mo 83 % Poirier (Abcarian)06 28 3 Mo 54 % Ky (New York) 07 42 3 Mo 81 % Christoforidis (Mineapolis) 07 57 3 Mo 40 % Cintron (USA) 07 28 3 Mo 54 % Abbas (Efron LA)07 17 7 Mo 24 % Safar (Wexner) 07 39 4 Mo 14 %

  16. Anal Fistula Plug: Results (Europe) Author Year n FU Healing Lenisa (I) 07 27 8 Mo 85 % Van Koperen (NL) 07 17 7 Mo 41 % Garg (Ind) 07 27 6 Mo 66 % Bohe (Sw) 07 32 6 Mo 66 % Thekkinkattil (UK)07 38 6 Mo 39 % AFP-Workshop 07 15-25 < 6 Mo 41-70 %

  17. Anal Fistula Plug: Results Germany (Follow up 6 Mo.) Author n FU Healing Schwandner (Gießen) 60 trans. Soetje (Wiesbaden) 59 trans. Scherer (Berlin) 25 Ftr/Fsu Schwandner (Regensburg) 19 trans. Herold (Mannheim) 18 trans Peters (Köln) 13 trans. Kolbus(Leipzig)7 trans. Pakravan (Düsseldorf) 6 trans

  18. Anal Fistula Plug: Results Germany (Follow up 6 Mo.) Author n FU Healing Schwandner (Gießen) 60 trans. 63 % Soetje (Wiesbaden) 59 trans. 74 % Scherer (Berlin) 25 Ftr/Fsu 48 % Schwandner (Regensburg) 19 trans. 61 % Herold (Mannheim) 18 trans 39 % Peters (Köln) 13 trans. 38 % Kolbus(Leipzig)7 trans 85 % Pakravan (Düsseldorf) 6 trans 66 %

  19. Author Year n FU Healing Abel (USA) 93 6 7 Mo 75 % Cintron (USA) 00 53 12 Mo 72 % Patrlj (Yug) 00 30 28 Mo 70 % Lindsey (GB) 02 17 17 Mo 43 % Chan (GB) 02 10 6 Mo 60 % Sentovich (USA) 03 36 22 Mo 69 % Zmora (USA) 03 10 12 Mo 33 % Buchanan (GB) 03 16 14 Mo 16 % Loungnarath (USA) 04 22 < 26 Mo 23 % Treatment Alternatives

  20. Treatment Alternatives

  21. Fistulectomy and Secondary Repair

  22. Secondary Repair: Results Author Year n Success Keighley (GB) 83 19 61 % Browning (GB) 84 97 78 % Fang (USA) 84 79 89 % Christiansen (DK) 87 23 60 % Laurberg (USA) 88 19 47 % Ctercteko (USA) 88 58 64 % Yoshioka (GB) 89 27 74 % Jacobs (NL) 90 37 83 % Fleshman (USA) 91 55 51 % Wexner (USA) 91 16 76 % Arnaud (F) 91 40 63 % Engel (NL) 94 55 76 % Oliveira (USA) 96 55 71 % Mölle (CH) 97 33 74 % Halverson (USA) 01 45 41 % EDZ (D) 04 32 87 % Total: 35 Studies: Success rate 75 % (41 – 89 %)

  23. Treatment Alternatives

  24. Fistulectomy and Primary Repair

  25. Fistulectomy and Primary Repair (2): Episioproctectomy

  26. Primary Repair: Results Author Year n Type Dehiscence Recurr. Incontinence Parakash (Ind) 85 120 distal - 2,5 % - Lux (D) 91 46 mixed 0 0% 20 % (1+2°) Christiansen (DK) 95 14 mixed - 15 % 21% (1+2°) Gemsenjäger (CH) 96 21 mixed 5 % 5 % 5 % Lewis (GB) 96 32 mixed - 9,5 % Roig (E) 99 31 mixed 4 % 10 % 24%(1+2°) Perez (E) 05 35 mixed - 6 % 12 % Herold (D) 05 34 mixed 8% (14%) 6 % - Perez (E) 06 16 mixed 0 6 % (improved) Herold (D) 06 84 mixed 5% (11%) 6 % no 3°

  27. 1 2 3 Primary Repair: Results correlated with involved Sphincter(1)

  28. √ √ 2,5% 4 % Primary Repair: Results correlated with involved Sphincter(2) Dehiscence: 0% - 20% Recurrence: 20% - 50%

  29. Total Healing Rate with Primary Reconstruction: 84 % EDZ - Results(preliminary) n = 148, 11/2004 – 10/2007, Follow up: 20 mo (12 - 48 mo) Total: n = 120 Total Healing: n = 114 (94%) Primary Healing: n = 95 (79%) • Re-Rekonstruktion: n = 6 • Healing (1 Stoma): n = 4 • Persisting Fistula: n = 2 Dehiscence: n = 6 ( 5%) Recurrence: n = 19 (16%) • Re-Do: n = 19 • Fistulectomy : n = 12 • Persisting Fistula: n = 4 • Rekonstruktion: n = 3(2)

  30. Treatment Alternatives

  31. Conclusion:

  32. Conclusion:

  33. Summary We are on the way ……. ….. but we are far from perfect !

More Related